Mental Health

StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update

TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare…

2 years ago

Aster Springs Expands Eating Disorder Treatment in Richmond, Virginia, With New Outpatient Location

BRENTWOOD, TN / ACCESSWIRE / November 14, 2023 / Odyssey Behavioral Healthcare ("Odyssey"), a nationally recognized leader in eating disorder…

2 years ago

Red Light Holland Re-Engages Former Health Minister, the Honourable, Tony P. Clement, as Senior Advisor to Advisory Board

Toronto, Ontario--(Newsfile Corp. - November 14, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

2 years ago

Jaguar Health Reports Third Quarter 2023 Financial Results

Net revenue increased 5% in Q3 2023 versus Q2 2023Top line results expected before Thanksgiving for company's phase 3 OnTarget…

2 years ago

QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results

25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit.  ●In Q3 2023,…

2 years ago

Acentra Health Awarded New Contract Supporting Utilization Management and Assessment Services for West Virginia Medicaid

Award builds on company’s 23-year state partnership to accelerate better health outcomes for Medicaid membersMCLEAN, Va., Nov. 14, 2023 (GLOBE…

2 years ago

atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights

Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and…

2 years ago

Will Campbell, CEO of Quantasy, Speaks on the Power of Mental Wellness in “Breaking and Entering Advertising” Podcast

LOS ANGELES, Nov. 13, 2023 /PRNewswire/ -- In the ever-evolving world of advertising, success is often measured by creativity, innovation,…

2 years ago

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

New updates designed to advance practice efficiency and patient outcomesMALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:…

2 years ago

VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Transformative capital raise of $88.2 million from leading healthcare investors provides funding for BET inhibitor programs through the end of…

2 years ago